In patients with type 2 diabetes, kallikrein-related peptidase 5, an enzyme responsible for the shedding of DPP4 from cell membrane, was induced in CD4+ T cells, suggesting that immune cell-derived DPP4 is responsible for reduced incretin effect in diabetes patients (180). This evidence concerns the gene DPP4 and diabetes mellitus.